{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T16:25:47Z","timestamp":1771863947239,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Institute of Health","award":["F32 CA236309"],"award-info":[{"award-number":["F32 CA236309"]}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","award":["1018894"],"award-info":[{"award-number":["1018894"]}],"id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1245\/s10434-022-11419-1","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T18:02:47Z","timestamp":1646157767000},"page":"3536-3546","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical Predictors of Pseudohypoxia-Type Pheochromocytomas"],"prefix":"10.1245","volume":"29","author":[{"given":"J. J.","family":"Baechle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Marincola","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. A.","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. S.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. C.","family":"Sol\u00f3rzano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. M.","family":"Kiernan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,1]]},"reference":[{"issue":"6","key":"11419_CR1","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/MPA.0b013e3181ebb4f0","volume":"39","author":"H Chen","year":"2010","unstructured":"Chen H, Sippel RS, Odorisio MS, Vinik AI, Lloyd RV, Pacak K. North American neuroendocrine tumor society (NANETS). The North American neuroendocrine tumor society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas. 2010;39(6):775\u201383. https:\/\/doi.org\/10.1097\/MPA.0b013e3181ebb4f0.","journal-title":"Pancreas"},{"issue":"5","key":"11419_CR2","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1245\/s10434-020-08220-3","volume":"27","author":"D Patel","year":"2020","unstructured":"Patel D, Phay JE, Yen TWF, Dickson PV, Wang TS, Garcia R, Yang AD, Sol\u00f3rzano CC, Kim LT. Update on pheochromocytoma and paraganglioma from the sso endocrine\/head and neck disease-site work group. Part 1 of 2: advances in pathogenesis and diagnosis of pheochromocytoma and paraganglioma. Ann Surg Oncol. 2020;27(5):1329\u201337. https:\/\/doi.org\/10.1245\/s10434-020-08220-3.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"11419_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.soc.2015.08.006","volume":"25","author":"CM Kiernan","year":"2016","unstructured":"Kiernan CM, Sol\u00f3rzano CC. Pheochromocytoma and paraganglioma: diagnosis, genetics, and treatment. Surg Oncol Clin N Am. 2016;25(1):119\u201338. https:\/\/doi.org\/10.1016\/j.soc.2015.08.006.","journal-title":"Surg Oncol Clin N Am"},{"issue":"4","key":"11419_CR4","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1677\/ERC-08-0049","volume":"15","author":"HJ Timmers","year":"2008","unstructured":"Timmers HJ, Brouwers FM, Hermus AR, Sweep FC, Verhofstad AA, Verbeek AL, Pacak K, Lenders JW. Metastases but not cardiovascular mortality reduces life expectancy following surgical resection of apparently benign pheochromocytoma. Endocr Relat Cancer. 2008;15(4):1127\u201333. https:\/\/doi.org\/10.1677\/ERC-08-0049.","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"11419_CR5","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1210\/jc.2012-3669","volume":"98","author":"RF Stolk","year":"2013","unstructured":"Stolk RF, Bakx C, Mulder J, Timmers HJ, Lenders JW. Is the excess cardiovascular morbidity in pheochromocytoma related to blood pressure or to catecholamines? J Clin Endocrinol Metab. 2013;98(3):1100\u20136. https:\/\/doi.org\/10.1210\/jc.2012-3669.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"11419_CR6","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1245\/s10434-020-08221-2","volume":"27","author":"D Patel","year":"2020","unstructured":"Patel D, Phay JE, Yen TWF, Dickson PV, Wang TS, Garcia R, Yang AD, Kim LT, Sol\u00f3rzano CC. Update on pheochromocytoma and paraganglioma from the SSO endocrine and head and neck disease site working group, Part 2 of 2: perioperative management and outcomes of pheochromocytoma and paraganglioma. Ann Surg Oncol. 2020;27(5):1338\u201347. https:\/\/doi.org\/10.1245\/s10434-020-08221-2.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"11419_CR7","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1245\/s10434-007-9489-2","volume":"14","author":"CC Solorzano","year":"2007","unstructured":"Solorzano CC, Lew JI, Wilhelm SM, Sumner W, Huang W, Wu W, Montano R, Sleeman D, Prinz RA. Outcomes of pheochromocytoma management in the laparoscopic era. Ann Surg Oncol. 2007;14(10):3004\u201310. https:\/\/doi.org\/10.1245\/s10434-007-9489-2.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"11419_CR8","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1210\/er.2017-00062","volume":"38","author":"J Crona","year":"2017","unstructured":"Crona J, Ta\u00efeb D, Pacak K. New perspectives on pheochromocytoma and paraganglioma: toward a molecular classification. Endocr Rev. 2017;38(6):489\u2013515. https:\/\/doi.org\/10.1210\/er.2017-00062.","journal-title":"Endocr Rev"},{"issue":"10","key":"11419_CR9","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/cancers1110150","volume":"11","author":"S N\u00f6lting","year":"2019","unstructured":"N\u00f6lting S, Ullrich M, Pietzsch J, et al. Current management of pheochromocytoma\/paraganglioma: a guide for the practicing clinician in the era of precision medicine. Cancers (Basel). 2019;11(10):1505. https:\/\/doi.org\/10.3390\/cancers1110150.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"11419_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrendo.2014.188","volume":"11","author":"J Favier","year":"2015","unstructured":"Favier J, Amar L, Gimenez-Roqueplo AP. Paraganglioma and phaeochromocytoma: from genetics to personalized medicine. Nat Rev Endocrinol. 2015;11(2):101\u201311. https:\/\/doi.org\/10.1038\/nrendo.2014.188.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"11419_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","volume":"31","author":"L Fishbein","year":"2017","unstructured":"Fishbein L, Leshchiner I, Walter V, et al. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017;31(2):181\u201393. https:\/\/doi.org\/10.1016\/j.ccell.2017.01.001.","journal-title":"Cancer Cell"},{"issue":"2","key":"11419_CR12","doi-asserted-by":"publisher","first-page":"101416","DOI":"10.1016\/j.beem.2020.101416","volume":"34","author":"A Buffet","year":"2020","unstructured":"Buffet A, Burnichon N, Favier J, Gimenez-Roqueplo AP. An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma. Best Pract Res Clin Endocrinol Metab. 2020;34(2):101416. https:\/\/doi.org\/10.1016\/j.beem.2020.101416.","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"issue":"6","key":"11419_CR13","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JW Lenders","year":"2014","unstructured":"Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, Naruse M, Pacak K, Young WF Jr. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915\u201342. https:\/\/doi.org\/10.1210\/jc.2014-1498.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"11419_CR14","doi-asserted-by":"publisher","first-page":"586857","DOI":"10.3389\/fendo.2020.586857","volume":"24","author":"S Peng","year":"2020","unstructured":"Peng S, Zhang J, Tan X, Huang Y, Xu J, Silk N, Zhang D, Liu Q, Jiang J. The VHL\/HIF axis in the development and treatment of pheochromocytoma\/paraganglioma. Front Endocrinol (Lausanne). 2020;24(11):586857. https:\/\/doi.org\/10.3389\/fendo.2020.586857.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"11419_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12022-012-9195-x","volume":"23","author":"A Casc\u00f3n","year":"2012","unstructured":"Casc\u00f3n A, Tennant DA. From transcriptional profiling to tumor biology in pheochromocytoma and paraganglioma. Endocr Pathol. 2012;23(1):15\u201320. https:\/\/doi.org\/10.1007\/s12022-012-9195-x.","journal-title":"Endocr Pathol"},{"issue":"12","key":"11419_CR16","doi-asserted-by":"publisher","first-page":"4865","DOI":"10.1210\/jc.2007-1253","volume":"92","author":"E Thou\u00ebnnon","year":"2007","unstructured":"Thou\u00ebnnon E, Elkahloun AG, Guillemot J, et al. Identification of potential gene markers and insights into the pathophysiology of pheochromocytoma malignancy. J Clin Endocrinol Metab. 2007;92(12):4865\u201372. https:\/\/doi.org\/10.1210\/jc.2007-1253.","journal-title":"J Clin Endocrinol Metab."},{"issue":"17","key":"11419_CR17","first-page":"5615","volume":"63","author":"AP Gimenez-Roqueplo","year":"2003","unstructured":"Gimenez-Roqueplo AP, Favier J, Rustin P, et al. Mutations in the SDHB gene are associated with extra-adrenal and\/or malignant phaeochromocytomas. Cancer Res. 2003;63(17):5615\u201321.","journal-title":"Cancer Res"},{"issue":"3","key":"11419_CR18","doi-asserted-by":"publisher","first-page":"302","DOI":"10.4158\/EP15725.OR","volume":"22","author":"H Turkova","year":"2016","unstructured":"Turkova H, Prodanov T, Maly M, et al. Characteristics and outcomes of metastatic SDHB and sporadic pheochromocytoma\/paraganglioma: a national institute of health study. Endocr Pract. 2016;22(3):302\u201314. https:\/\/doi.org\/10.4158\/EP15725.OR.","journal-title":"Endocr Pract"},{"issue":"12","key":"11419_CR19","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1136\/jmedgenet-2012-101192","volume":"49","author":"LT van Hulsteijn","year":"2012","unstructured":"van Hulsteijn LT, Dekkers OM, Hes FJ, Smit JW, Corssmit EP. Risk of malignant paraganglioma in SDHB-mutation and SDHD-mutation carriers: a systematic review and meta-analysis. J Med Genet. 2012;49(12):768\u201376. https:\/\/doi.org\/10.1136\/jmedgenet-2012-101192.","journal-title":"J Med Genet"},{"issue":"4","key":"11419_CR20","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1210\/jc.2018-02411","volume":"104","author":"A Buffet","year":"2019","unstructured":"Buffet A, Ben Aim L, Leboulleux S, et al. Positive impact of genetic test on the management and outcome of patients with paraganglioma and\/or pheochromocytoma. J Clin Endocrinol Metab. 2019;104(4):1109\u201318. https:\/\/doi.org\/10.1210\/jc.2018-02411.","journal-title":"J Clin Endocrinol Metab"},{"issue":"34","key":"11419_CR21","doi-asserted-by":"publisher","first-page":"8812","DOI":"10.1200\/JCO.2005.03.1484","volume":"23","author":"L Amar","year":"2005","unstructured":"Amar L, Bertherat J, Baudin E, et al. Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol. 2005;23(34):8812\u20138. https:\/\/doi.org\/10.1200\/JCO.2005.03.1484.","journal-title":"J Clin Oncol"},{"key":"11419_CR22","first-page":"93","volume-title":"Blueprints cardiology","author":"Eric H Awtry","year":"2006","unstructured":"Awtry Eric H, Jeon Cathy, Ware Molly G. Blueprints cardiology. 2nd edn. Malden, Mass: Blackwell; 2006. p. 93.","edition":"2"},{"issue":"12","key":"11419_CR23","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1245\/s10434-014-3847-7","volume":"21","author":"CM Kiernan","year":"2014","unstructured":"Kiernan CM, Du L, Chen X, et al. Predictors of hemodynamic instability during surgery for pheochromocytoma. Ann Surg Oncol. 2014;21(12):3865\u201371. https:\/\/doi.org\/10.1245\/s10434-014-3847-7.","journal-title":"Ann Surg Oncol"},{"key":"11419_CR24","doi-asserted-by":"crossref","unstructured":"Thiele C, Hirschfeld G, Cutpointr: improved estimation and validation of optimal cutpoints in R. arXiv. 2020.","DOI":"10.18637\/jss.v098.i11"},{"issue":"6","key":"11419_CR25","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/jso.24961","volume":"117","author":"A Asban","year":"2018","unstructured":"Asban A, Kluijfhout WP, Drake FT, et al. Trends of genetic screening in patients with pheochromocytoma and paraganglioma: 15-year experience in a high-volume tertiary referral center. J Surg Oncol. 2018;117(6):1217\u201322. https:\/\/doi.org\/10.1002\/jso.24961.","journal-title":"J Surg Oncol"},{"issue":"9","key":"11419_CR26","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.4158\/EP171875.OR","volume":"23","author":"TM Gallagher","year":"2017","unstructured":"Gallagher TM, Bucciarelli M, Kavalukas SL, Baker MJ, Saunders BD. Attitudes toward genetic counseling and testing in patients with inherited endocrinopathies. Endocr Pract. 2017;23(9):1039\u201344. https:\/\/doi.org\/10.4158\/EP171875.OR.","journal-title":"Endocr Pract"},{"key":"11419_CR27","unstructured":"Education Genetics. Pheo Para Alliance website. Accessed April 20, 2021. https:\/\/pheopara.org\/education\/genetics."},{"issue":"1","key":"11419_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.surg.2017.05.025","volume":"163","author":"P Nockel","year":"2018","unstructured":"Nockel P, El Lakis M, Gaitanidis A, et al. Preoperative genetic testing in pheochromocytomas and paragangliomas influences the surgical approach and the extent of adrenal surgery. Surgery. 2018;163(1):191\u20136. https:\/\/doi.org\/10.1016\/j.surg.2017.05.025.","journal-title":"Surgery"},{"issue":"1","key":"11419_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1677\/ERC-10-0211","volume":"18","author":"G Eisenhofer","year":"2010","unstructured":"Eisenhofer G, Pacak K, Huynh TT, Qin N, Bratslavsky G, Linehan WM, Mannelli M, Friberg P, Grebe SK, Timmers HJ, Bornstein SR, Lenders JW. Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma. Endocr Relat Cancer. 2010;18(1):97\u2013111. https:\/\/doi.org\/10.1677\/ERC-10-0211.","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"11419_CR30","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1373\/clinchem.2010.153320","volume":"57","author":"G Eisenhofer","year":"2011","unstructured":"Eisenhofer G, Lenders JW, Timmers H, Mannelli M, Grebe SK, Hofbauer LC, Bornstein SR, Tiebel O, Adams K, Bratslavsky G, Linehan WM, Pacak K. Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. Clin Chem. 2011;57(3):411\u201320. https:\/\/doi.org\/10.1373\/clinchem.2010.153320.","journal-title":"Clin Chem"},{"issue":"2","key":"11419_CR31","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1471-4159.2009.05978.x","volume":"109","author":"TC Tai","year":"2009","unstructured":"Tai TC, Wong-Faull DC, Claycomb R, Wong DL. Hypoxic stress-induced changes in adrenergic function: role of HIF1 alpha. J Neurochem. 2009;109(2):513\u201324. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.05978.x.","journal-title":"J Neurochem."},{"issue":"6","key":"11419_CR32","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1210\/jc.2004-1899","volume":"90","author":"TW Vogel","year":"2005","unstructured":"Vogel TW, Brouwers FM, Lubensky IA, et al. Differential expression of erythropoietin and its receptor in von Hippel\u2013Lindau-associated and multiple endocrine neoplasia type 2-associated pheochromocytomas. J Clin Endocrinol Metab. 2005;90(6):3747\u201351. https:\/\/doi.org\/10.1210\/jc.2004-1899.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"11419_CR33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12022-017-9469-4","volume":"28","author":"Q Liu","year":"2017","unstructured":"Liu Q, Wang Y, Tong D, et al. A somatic HIF2\u03b1 mutation-induced multiple and recurrent pheochromocytoma\/paraganglioma with polycythemia: clinical study with literature review. Endocr Pathol. 2017;28(1):75\u201382. https:\/\/doi.org\/10.1007\/s12022-017-9469-4.","journal-title":"Endocr Pathol."},{"issue":"5","key":"11419_CR34","doi-asserted-by":"publisher","first-page":"E908","DOI":"10.1210\/jc.2013-1217","volume":"98","author":"D Ta\u00efeb","year":"2013","unstructured":"Ta\u00efeb D, Yang C, Delenne B, et al. First report of bilateral pheochromocytoma in the clinical spectrum of HIF2A-related polycythemia-paraganglioma syndrome. J Clin Endocrinol Metab. 2013;98(5):E908\u201313. https:\/\/doi.org\/10.1210\/jc.2013-1217.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"11419_CR35","first-page":"349","volume":"48","author":"MA Rezkalla","year":"1995","unstructured":"Rezkalla MA, Rizk SN, Ryan JJ. Pheochromocytoma associated with polycythemia: case report. S D J Med. 1995;48(10):349\u201351.","journal-title":"S D J Med"},{"issue":"3","key":"11419_CR36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3949\/ccjm.38.3.121","volume":"38","author":"JD Battle Jr","year":"1971","unstructured":"Battle JD Jr, Alfidi RJ, Straffon RA. Polycythemia secondary to pheochromocytoma. Report of a case. Cleve Clin Q. 1971;38(3):121\u20134. https:\/\/doi.org\/10.3949\/ccjm.38.3.121.","journal-title":"Cleve Clin Q"},{"issue":"7247","key":"11419_CR37","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/s0140-6736(62)90008-9","volume":"2","author":"ID Ramsay","year":"1962","unstructured":"Ramsay ID, Langlands JH. Phaeochromocytoma with hypotension and polycythaemia. Lancet. 1962;2(7247):126\u20138. https:\/\/doi.org\/10.1016\/s0140-6736(62)90008-9.","journal-title":"Lancet"},{"issue":"12","key":"11419_CR38","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1172\/JCI63924","volume":"122","author":"Q Liu","year":"2012","unstructured":"Liu Q, Davidoff O, Niss K, Haase VH. Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis. J Clin Invest. 2012;122(12):4635\u201344. https:\/\/doi.org\/10.1172\/JCI63924.","journal-title":"J Clin Invest"},{"issue":"3","key":"11419_CR39","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1210\/jc.2006-2315","volume":"92","author":"HJ Timmers","year":"2007","unstructured":"Timmers HJ, Kozupa A, Eisenhofer G, et al. Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas. J Clin Endocrinol Metab. 2007;92(3):779\u201386. https:\/\/doi.org\/10.1210\/jc.2006-2315.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"11419_CR40","doi-asserted-by":"publisher","first-page":"e4661","DOI":"10.1210\/clinem\/dgaa608","volume":"105","author":"H Wachtel","year":"2020","unstructured":"Wachtel H, Hutchens T, Baraban E, et al. Predicting metastatic potential in pheochromocytoma and paraganglioma: a comparison of PASS and GAPP scoring systems. J Clin Endocrinol Metab. 2020;105(12):e4661\u201370. https:\/\/doi.org\/10.1210\/clinem\/dgaa608.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-11419-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-11419-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-11419-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T21:11:10Z","timestamp":1651785070000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-11419-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["11419"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-11419-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,1]]},"assertion":[{"value":"9 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors report having no conflicts of interest relevant to this study","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}